|
|
Exact Sciences Corporation - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Exact Sciences Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Exact Sciences Corporation. The Group's principal activities are to develop and commercialize proprietary DNA based tests for the early detection of cancer and other types of common cancers. PreGen-Plus utilizes PreGen technologies to isolate the minute amounts of human DNA shed from the colon into stool and then identifies mutations in DNA shed from abnormal cells indicative of colorectal cancer and pre-cancerous lesions. It also offers PreGen-Plus through LabCorp, in the United States with 35 primary laboratories and over 1,600 patient service centers. LabCorp is the exclusive licensee, in the United States and Canada, of the technology that surrounds PreGen-Plus.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|